A Glimpse Into The Expert Outlook On Eli Lilly Through 28 Analysts
Portfolio Pulse from Benzinga Insights
Eli Lilly (NYSE:LLY) has received mixed analyst ratings over the past three months, with a majority being somewhat bullish. Analysts have set a 12-month average price target of $964.46, up from $915.68, with a high estimate of $1125.00. The company shows strong financial performance with significant revenue growth and profitability metrics.
September 09, 2024 | 8:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Eli Lilly has received a mix of bullish and somewhat bullish ratings from analysts, with a 12-month average price target of $964.46, indicating positive sentiment. The company's strong financial performance, including a 35.98% revenue growth, supports this outlook.
The majority of analysts are somewhat bullish on Eli Lilly, with a significant increase in the average price target. The company's strong financial metrics, such as high revenue growth and profitability, support a positive short-term outlook.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100